A short study in the treatment of hot flashes with buccal administration of 17-β estradiol

Maturitas

Volumn 49, Issue 2, 2004, Pages 140-147

  Gass, Margery S ^a   Rebar, Robert W ^b   Cuffie Jackson, Cynthia ^c   Cedars, Marcelle I ^d   Lobo, Rogerio A ^e   Shoupe, Donna ^f   Judd, Howard L ^g   Buyalos, Richard P ^g   Clisham, Paul R ^h  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Buccal estradiol; Hot flushes; Maturation index

Indexed keywords

ESTRADIOL; ESTRONE; FOLLITROPIN; LUTEINIZING HORMONE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HOT FLUSH; HUMAN; INFORMATION PROCESSING; LEUKORRHEA; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MASTALGIA; MATURATION; MEASUREMENT; MOUTH DISEASE; PARESTHESIA; POSTMENOPAUSE; PREMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TABLET FORMULATION; TASTE DISORDER; VAGINA; VAGINA BLEEDING;

ADMINISTRATION, BUCCAL; ADULT; AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLICLE STIMULATING HORMONE; HOT FLASHES; HUMANS; LUTEINIZING HORMONE; MIDDLE AGED; PILOT PROJECTS; POSTMENOPAUSE; TREATMENT OUTCOME;

EID: 4944232711     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2003.12.004     Document Type: Article

References (20)

1. McKinlay S.M., Jefferys M. The menopausal syndrome. Br. J. Prev. Soc. Med. 28:1974;108-115
2. Ettinger B., Pressman A., Silver P. Effect of age on reasons for initiation and discontinution of hormone replacement therapy. Menopause. 6:1999;282-289
3. Judd H.L., Meldrum D.R., Deftos L.J., Henderson B.E. Estrogen replacement therapy: indications and complications. Ann. Int. Med. 98:1983;195-205
4. Recker R.R., Saville P.D., Heaney R.P. Effect of estrogens and calcium carbonate on bone loss in postmenopausal women. Ann. Int. Med. 87:1977;649-655
5. Geola F.L., Frumar A.M., Tataryn I.V., Lu K.H., Hershman J.M., Eggena P., et al. Biological effects of various doses of conjugated equine estrogens in postmenopausal women. J. Clin. Endocrinol. Metab. 51:1980;620-625
6. Pfeffer R.I. Estrogen use, hypertension and stroke in postmenopausal women. J. Chronic. Dis. 31:1978;389-398
7. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., Vittinghoff E. for the Heart and Estrogen/Progestin Replacement Study Research Group Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 280(7):1998;605-613
8. Steingold K.A., Laufer L., Chetkowski R.J., Defazio J.D., Matt D.W., Meldrum D.R., Judd H.L. Treatment of hot flashes with transdermal estradiol administration. J. Clin. Endocrinol. Metab. 61:1985;627-632
9. Gordon S.F. Clinical experience with a seven-day estradiol transdermal system for estrogen replacement therapy. Am. J. Obstet. Gynecol. 173(3):1995;998-1004
10. Good W.R., John V.A., Ramirez J.M., Higgins J.E. Comparison of Alora estradiol matrix transdermal delivery system with oral conjugated equine estrogen therapy in relieving menopausal symptoms. Climacteric. 2:1999;29-36
11. Speroff L., Whitcomb R.W., Kempfert N.J., Boyd R.A., Paulissen J.B., Rowan J.P. Efficacy and local tolerance of a low-dose, 7-day matrix estradiol transdermal system in the treatment of menopausal vasomotor symptoms. Obstet. Gynecol. 88:1996;587-592
12. de Vrijer B., Snijders M.P.M.L., Troostwijk A.L., Thé S., Iding R.J., Friese S., et al. Efficacy and tolerability of a new estradiol delivering matrix patch (Estraderm MX) in postmenopausal women. Maturitas. 34:2000;47-55
13. Utian W.H., Shoupe D., Bachmann G., Pinkerton J.V., Pickar J.H. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil. Steril. 75:2001;1065-1079
14. Tataryn I.V., Lomax P., Meldrum D.R., Bajorek J.G., Chesarek W., Judd H.L. Objective techniques for the assessment of postmenopausal hot flashes. Obstet. Gynecol. 57:1981;340-344
15. Meldrum D.R., Shamonki I.M., Frumar A.M., Tataryn I.V., Chang R.J., Judd H.L. Elevations in skin temperature of the finger as an objective index of postmenopausal hot flashes: standardization of the technique. Am. J. Obstet. Gynecol. 135:1979;713-717
16. Laufer L.R., DeFazio J.L., Lu J.K.H., Meldrum D.R., Eggena P., Sambhi M.P., et al. Estrogen replacement therapy by transdermal estradiol administration. Am. J. Obstet. Gynecol. 146:1983;533-540
17. Yoshimura T., Okamura H. Short term oral estriol treatment restores normal premenopausal vaginal flora to elderly women. Maturitas. 39:2001;253-257
18. Chetkowski R.J., Meldrum D.R., Steingold K.A., Randle D., Lu J.K., Eggena P., et al. Biologic effects of transdermal estradiol. N. Engl. J. Med. 314:1986;1615-1620
19. Rigg L.A., Milanes B., Villanueva B., Yen S.S. Efficacy of intravaginal and intranasal administration of micronized estradiol-17beta. J. Clin. Endocrinol. Metab. 45(6):1977;1261-1264
20. Buch A., Shen L., Kelly S., Sahota R., Brezovic C., Bixler C., Powell J. Steady-state bioavailability of estradiol from two matrix transdermal delivery systems, Alora and Climara. Menopause. 5:1998;107-112